Keyphrases
Tumor Necrosis Factor-α
100%
Nuclear factor-κB
100%
Bleomycin-induced Pulmonary Fibrosis
100%
Myofibroblast Differentiation
100%
Lung Resident Mesenchymal Stem Cells (LR-MSCs)
100%
Pulmonary Fibrosis
50%
Nuclear factor-κB Pathway
50%
Catenin
33%
Cell Necrosis
33%
Transcription Factor
16%
Decreased Expression
16%
Treatment Strategy
16%
Effective Treatment
16%
Inflammatory Cytokines
16%
Lung Disease
16%
Therapeutic Strategies
16%
Lung Tissue
16%
Unknown Cause
16%
Chronic Progressive
16%
Idiopathic Pulmonary Fibrosis
16%
Bleomycin
16%
P65 Subunit
16%
Nuclear factor-κB p65
16%
Medicine and Dentistry
Tumor Necrosis Factor
100%
Mesenchymal Stem Cell
100%
Immunoglobulin Enhancer Binding Protein
100%
Myofibroblast
100%
Bleomycin-Induced Pulmonary Fibrosis
100%
Lung
100%
Pulmonary Fibrosis
50%
Catenin
33%
Silo-Filler's Disease
16%
Idiopathic Pulmonary Fibrosis
16%
Cell Signaling Pathway
16%
Transcription Factor RelA
16%
Inflammatory Cytokine
16%
Transcription Factors
16%
Bleomycin
16%
Diseases
16%
Pharmacology, Toxicology and Pharmaceutical Science
Bleomycin-Induced Pulmonary Fibrosis
100%
Tumor Necrosis Factor
100%
Immunoglobulin Enhancer Binding Protein
100%
Lung Fibrosis
50%
Catenin
33%
Bleomycin
16%
Cytokine
16%
Lung Disease
16%
Fibrosing Alveolitis
16%
Transcription Factor RelA
16%
Transcription Factors
16%
Diseases
16%
Immunology and Microbiology
Tumor Necrosis Factor
100%
Mesenchymal Stem Cell
100%
Immunoglobulin Enhancer Binding Protein
100%
Myofibroblast
100%
Catenin
33%
Proinflammatory Cytokine
16%
Transcription Factor RelA
16%
Transcription Factors
16%